Cadila Healthcare has reported a consolidated net profit of Rs 100 crore in the second quarter of FY12, a massive fall of 41.2% as compared to Rs 170 crore in the corresponding quarter of last fiscal.
Consolidated net sales jumped 10% to Rs 1,220 crore from Rs 1,110 crore during the same period.
In the July-September quarter,
* Zydus Cadila acquired German company, Bremer Pharma GmbH, from ICICI Venture, gaining global footprint in animal healthcare business
* The manufacturing plant of the company at Baddi, Himachal Pradesh has received approval from USFDA.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment